558
Participants
Start Date
January 31, 2007
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Budesonide/formoterol (SYMBICORT) pMDI
SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily
Budesonide HFA pMDI
Budesonide Hydrofluoroalkane (HFA) pressurised metered dose inhaler (pMDI) 160 μg x 2 actuations twice daily
Research Site, Anaheim
Research Site, Chula Vista
Research Site, Fresno
Research Site, Fullerton
Research Site, Los Angeles
Research Site, National City
Research Site, Rancho Cordova
Research Site, Rancho Mirage
Research Site, Riverside
Research Site, Sacramento
Research Site, San Diego
Research Site, San Francisco
Research Site, Stockton
Research Site, Torrance
Research Site, Pueblo
Research Site, Largo
Research Site, Miami
Research Site, Naranja
Research Site, North Miami
Research Site, Orlando
Research Site, Panama City
Research Site, South Miami
Research Site, Chicago
Research Site, Newburgh
Research Site, Oklahoma City
Research Site, Philadelphia
Research Site, Boerne
Research Site, El Paso
Research Site, Fort Worth
Research Site, Houston
Research Site, San Antonio
Research Site, Spring
Research Site, Aguas Buenas
Research Site, Caquas
Research Site, Cidra
Research Site, Levittown
Research Site, Ponce
Research Site, SanJuan
Research Site, Trujillo Alto
Lead Sponsor
AstraZeneca
INDUSTRY